Phase II Study With Ga101-DHAP as Induction Therapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Patients Before High-Dose Chemotherapy BEAM With Autologous Stem Cell Transplantation (ASCT)
Phase of Trial: Phase II
Latest Information Update: 22 Jun 2017
At a glance
- Drugs Obinutuzumab (Primary) ; Cisplatin; Cytarabine; Dexamethasone; Pegfilgrastim
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- Acronyms GIOTTO
- 10 Jun 2017 Biomarkers information updated
- 15 Jun 2016 Planned End Date changed from 1 Jun 2017 to 1 Oct 2021.
- 15 Jun 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Oct 2018.